Rhumbline Advisers Sells 8,341 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Rhumbline Advisers cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 684,727 shares of the medical equipment provider’s stock after selling 8,341 shares during the quarter. Rhumbline Advisers’ holdings in Intuitive Surgical were worth $357,400,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of ISRG. State Street Corp raised its holdings in shares of Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the period. FMR LLC increased its position in Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares in the last quarter. Geode Capital Management LLC increased its position in Intuitive Surgical by 1.9% in the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after buying an additional 143,440 shares in the last quarter. Fisher Asset Management LLC boosted its holdings in Intuitive Surgical by 1.8% in the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock worth $2,349,441,000 after acquiring an additional 86,208 shares in the last quarter. Finally, Baillie Gifford & Co. grew its stake in Intuitive Surgical by 0.6% in the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after acquiring an additional 24,183 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Up 0.7 %

Intuitive Surgical stock opened at $595.55 on Friday. The company has a market capitalization of $212.12 billion, a P/E ratio of 92.91, a P/E/G ratio of 5.67 and a beta of 1.39. The firm has a 50 day moving average price of $558.58 and a 200-day moving average price of $518.00. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 6,348 shares of company stock valued at $3,587,582. Company insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of a number of research reports. Leerink Partners upped their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. CICC Research assumed coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective on the stock. Royal Bank of Canada lifted their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Jefferies Financial Group upped their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Finally, Bernstein Bank lifted their price target on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.